Skip to content

Comparison of oliceridine and morphine in postoperative analgesia in total laparoscopic hysterectomy, a clinical double-blind controlled trial

Comparison of oliceridine and morphine in postoperative analgesia in total laparoscopic hysterectomy, a clinical double-blind controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086706
Enrollment
Unknown
Registered
2024-07-09
Start date
2024-09-28
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group B:Postoperative analgesia: Intravenous oliceridine 1.5 mg loading dose, 10 minutes later connected to an intravenous analgesic pump 0.3 mg/Kg oliceridine with normal saline to 100 ml at a rate
Group D:Postoperative analgesia: Intravenous morphine 4 mg loading dose, 10 minutes later connected to an intravenous analgesic pump 1 mg/Kg morphine with normal saline to 100 ml at a rate of 2 ml/h.

Sponsors

Anqing Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) patients undergoing elective total laparoscopic hysterectomy; 2) ASA classification I-III; 3) Age 18-60 years old; 4) BMI 18-28Kg/m^2 and weight >40Kg; (5) Patients voluntarily accepted this trial and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) severe cardiac, pulmonary, hepatic and renal dysfunction 2) History of psychiatric illness or chronic use of psychotropic drugs (dementia, schizophrenia), chronic analgesic drugs, alcohol abuse 3) Patients with severe infections 4) Patients with brain dysfunction such as speech communication, hearing impairment or stroke, who are unable to communicate. 5) Pre-operative PaO2<60 mmHg or SpO2<92%. 6) Participation in a clinical study of another drug within the last 30 days.

Design outcomes

Primary

MeasureTime frame
Resting and exercise VAS pain scores;

Secondary

MeasureTime frame
Incidence of postoperative adverse events;Hemodynamic parameters;

Countries

China

Contacts

Public ContactDuan Jinjuan

Anqing Municipal Hospital

djjayd223@163.com+86 189 0966 5698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026